Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,446.00
-8.90 (-0.61%)
Nov 12, 2026, 3:30 PM IST
Alivus Life Sciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Alivus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of ₹1,676. The average 1-year stock price forecast is 15.92% higher than the current stock price, while the lowest is ₹1,330 (-8.02%) and the highest is ₹2,060 (+42.46%).
Price Target: ₹1,676 (+15.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alivus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
28.65B
from 25.52B
Increased by 12.27%
Revenue Next Year
32.26B
from 28.65B
Increased by 12.61%
EPS This Year
60.34
from 47.56
Increased by 26.87%
EPS Next Year
66.46
from 60.34
Increased by 10.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.